DR GC CHAJED'S PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: F81025 | BASILDON, SS16 5AD
Showing results 101-150 of 515
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Pramipexole | 299 | 15.6K | £2.3K | +204.5% ▲ |
| Pizotifen malate | 298 | 16.2K | £696 | +261.6% ▲ |
| Estradiol with progestogen | 296 | 8,081 | £7.5K | -13.1% ▼ |
| Mometasone furoate | 295 | 321 | £2.5K | -26.5% ▼ |
| Betahistine hydrochloride | 290 | 24.5K | £898 | +21.5% ▲ |
| Morphine sulfate | 282 | 59.0K | £2.3K | -57.0% ▼ |
| Thiamine hydrochloride | 282 | 15.8K | £419 | -46.5% ▼ |
| Nebivolol | 277 | 13.3K | £3.5K | +161.3% ▲ |
| Other emollient preparations | 276 | 149.5K | £1.9K | -54.0% ▼ |
| BeclometDiprop/Formoterol/Glycopyrronium (Corticosteroids) | 270 | 277 | £12.3K | +61.4% ▲ |
| Tamsulosin and dutasteride hydrochloride | 270 | 8,234 | £2.6K | +672.5% ▲ |
| Fluticasone furoate | 267 | 268 | £1.8K | +37.8% ▲ |
| Olanzapine | 263 | 8,365 | £1.6K | -29.0% ▼ |
| Mirabegron | 252 | 8,576 | £7.9K | -37.3% ▼ |
| Hydroxychloroquine sulfate | 250 | 11.4K | £514 | +29.1% ▲ |
| Sodium valproate | 235 | 26.2K | £3.3K | -26.1% ▼ |
| 234 | 27.4K | £811 | +174.8% ▲ | |
| Oxycodone hydrochloride | 229 | 15.9K | £5.8K | -10.5% ▼ |
| Nicotine | 225 | 6,317 | £5.5K | +298.3% ▲ |
| Semaglutide | 224 | 2,660 | £21.1K | -7.0% ▼ |
| Finasteride | 220 | 6,923 | £243 | -66.4% ▼ |
| Letrozole | 220 | 6,468 | £663 | +17.8% ▲ |
| Calcipotriol | 215 | 20.3K | £11.2K | +26.3% ▲ |
| Clonidine hydrochloride | 209 | 26.5K | £8.3K | +291.8% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 202 | 19.7K | £741 | -34.1% ▼ |
| 201 | 215 | £248 | -8.8% ▼ | |
| Dexamethasone | 200 | 1,055 | £658 | +16.3% ▲ |
| Buprenorphine | 192 | 1,901 | £3.2K | -47.6% ▼ |
| Glyceryl trinitrate | 190 | 487 | £476 | -19.7% ▼ |
| Tiotropium bromide | 190 | 3,226 | £5.4K | -37.5% ▼ |
| Ibuprofen | 190 | 19.9K | £850 | -62.6% ▼ |
| Prochlorperazine maleate | 189 | 10.0K | £635 | -6.5% ▼ |
| Atenolol | 186 | 9,048 | £198 | -69.2% ▼ |
| Biphasic isophane insulin | 186 | 1,403 | £6.1K | +66.7% ▲ |
| Fluticasone propionate (Inhalation) | 185 | 229 | £6.0K | -52.2% ▼ |
| Risperidone | 183 | 10.5K | £986 | -27.7% ▼ |
| Duloxetine hydrochloride | 182 | 8,440 | £1.0K | -71.4% ▼ |
| Progesterone | 180 | 14.3K | £3.1K | -57.0% ▼ |
| Carbocisteine | 176 | 22.0K | £539 | -67.0% ▼ |
| Mesalazine (Systemic) | 175 | 19.8K | £8.8K | -26.9% ▼ |
| 172 | 33.1K | £1.8K | +69.3% ▲ | |
| Co-careldopa (Carbidopa/levodopa) | 171 | 18.3K | £1.9K | -24.3% ▼ |
| Ranolazine | 169 | 10.1K | £1.9K | -0.6% vs avg |
| Irbesartan | 166 | 6,958 | £326 | -31.9% ▼ |
| Fluticasone propionate (Nasal) | 164 | 619 | £2.0K | +12.6% ▲ |
| Medroxyprogesterone acetate | 160 | 160 | £916 | +32.5% ▲ |
| Tirzepatide | 159 | 194 | £17.3K | -18.1% ▼ |
| Cetirizine hydrochloride | 157 | 13.7K | £632 | -68.6% ▼ |
| Carbamazepine | 157 | 35.8K | £1.9K | -47.1% ▼ |
| Aripiprazole | 155 | 4,380 | £908 | -39.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.